RxDoctor Payments Data

Sie Thomas

Family · Dallas, TXNPI 1164582011

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $180,298 of the $197,376 with a category attached, or 91.3%. AbbVie accounts for 99.7% of it on its own, with 3 other manufacturers making up the rest. Among family clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$197,377in general payments, 2019–2025

Across 346 payments — averaging $570.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$197K
  • Merz North America, Inc.$312
  • Revance Therapeutics, Inc.$126
  • Galderma Laboratories, L.p.$75

What the payments were for

  • Speaking & faculty fees$180,29891%
  • Travel & lodging$10,7245%
  • Food & beverage$6,3383%
  • Education$170%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)328$196,864
Merz North America, Inc.12$312
Revance Therapeutics, Inc.3$126
Galderma Laboratories, L.p.3$75

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$197,377 in reported general payments places this provider in the 95th percentile of 15,456 family providers in Texas.

See all family providers in Texas

Other family in Dallas

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →